David Hou Awarded 2022 ABTA Lucien Rubinstein Award for ‘B Cell Vaccine Promotes Anti-Glioma Immunity Through Modulating CD8+ T Cells’
David Hou is awarded for his research on leveraging a B cell vaccine to improve immunotherapy treatment for GBM.
Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.
